Delray Beach, FL, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for accelerated innovation The ...

There has been a recent revival in interest in peptide therapeutic development, with five of the top-selling drugs being peptides or proteins (Enbrel, Remicade, Humira, Avastin, MabThera) and many ...

The Peptide-Builder is designed for peptide chemists who want to make high-quality peptides quickly and easily at a laboratory scale. Peptides are synthesized sequentially and fully automated either ...

Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...

A peptide sequence that performs well at micromole scale may behave unpredictably at gram or kilogram scale. Coupling efficiency, acceptable with high reagent excess, can drop when equivalents are ...

The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...

Chromatography industry faces AI adoption challenges, workforce issues, and budget constraints, with biopharmaceutical sectors showing career growth. Peptide science is revolutionized by GLP-1 drugs, ...

In a recent study published in the Journal of the American Chemical Society, researchers present the second-generation NTB bicyclic stereodiversified peptide library. Study: MYC-Targeting Inhibitors ...